Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-11-14 00:00:00 ET · period of report 2023-11-10 · accession 0001968202-23-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-14 | 2023-11-10 | REGN | STAHL NEIL | EVP Research, Development | G - Gift | $0.00 | -400 | 52.7K | -0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-10 | G | D | 400 | $0.00 | 52,700 | D | — | — |